Modeling Cancer: Integrating scales, disciplines and programs (ICBP & PSOC)
This IMO hosted special meeting brought together all of the mathematical and computational cancer
modelers within both the Integrative Cancer Biology Program (ICBP) and Physical Science Oncology
Centers (PSOC) and was held in Tampa, FL on February 26-28, 2015.
“With the increasing importance of mathematical models of cancer as a means to both better
understand and treat the disease as well as integrate disparate data, there is a need to share
our experience in developing, applying and integrating these models at the interface. This
meeting offered a key forum for theoretical modelers of cancer to meet and discuss the computational
and mathematical challenges we face, the creative solutions to those challenges, work in progress,
and opportunities for sharing and collaboration across programs. This meeting also provided an
opportunity for participants to go into much more depth concerning the theoretical tools and approaches
than is normally possible in the context of the larger annual program meetings and builds on the success
of two previous ICBP centric meetings held in Berkeley (2010) and Tampa (2012).This meeting was co-chaired
by two modelers from the ICBP, Sandy Anderson (Moffitt) and Claire Tomlin (Berkeley) , and two modelers
from the PSOC, Franziska Michor (Dana-Farber) and Kristin Swanson (Northwestern).” — Sandy Anderson (Moffitt)
Levy presents a minimal model of drug resistance in cancer, linear, deterministic, well mixed #icbppsocmath http://t.co/b0N4JAoP7y
@CancerConnector, Fri Feb 27 14:32:51 +0000 2015, via Twitter for iPhone
RT @ara_anderson: Getting to know one another: Science speed dating @mathonco #icbppsocmath http://t.co/chNdP0nygs
@CancerConnector, Fri Feb 27 14:32:55 +0000 2015, via Twitter for iPhone
RT @ara_anderson: 1st presentation by Doron Levy: The dynamics of drug resistance in cancer #icbppsocmath @NCIPhySci @mathonco http://t.co/wyEFtwlmjQ
@CancerConnector, Fri Feb 27 14:32:58 +0000 2015, via Twitter for iPhone
RT @ara_anderson: Levy presents a minimal model of drug resistance in cancer, linear, deterministic, well mixed #icbppsocmath http://t.co/b0N4JAoP7y
@CancerConnector, Fri Feb 27 14:33:28 +0000 2015, via Twitter for iPhone
RT @dbasanta: Levy: #mathonco studies optimal protocol for scheduling, infusion vs pulsating therapies and how to do combinations of drugs #icbppsocmath
RT @ara_anderson: Sun says stem cells migrate 100mirons/day & adding migration to his compartment model fits data well #icbppsocmath http://t.co/w8aAs9tyr6
RT @ara_anderson: Artists Ziemys: Drug delivery modeling deciphers deciphers role of microenvironment in pharmacokinetics #icbppsocmath http://t.co/NPP2O1ohWd
RT @ara_anderson: Artists Ziemys: Drug delivery modeling deciphers deciphers role of microenvironment in pharmacokinetics #icbppsocmath http://t.co/NPP2O1ohWd
Xavier: shows us a beautiful integration between in vitro, in silico & in vivo systems #icbppsocmath @mathonco http://t.co/ADDD3R7jGl
@CancerSysBio, Fri Feb 27 16:50:11 +0000 2015, via Twitter for Mac
RT @ara_anderson: Xavier: shows us a beautiful integration between in vitro, in silico & in vivo systems #icbppsocmath @mathonco http://t.co/ADDD3R7jGl
RT @ara_anderson: Xavier: shows us a beautiful integration between in vitro, in silico & in vivo systems #icbppsocmath @mathonco http://t.co/ADDD3R7jGl
@CancerSysBio Great work on modeling extrinsic sources of heterogeneity. T
ME gradients magnify stochastic differences in ABMs #icbppsocmath
@CancerSysBio, Fri Feb 27 16:57:01 +0000 2015, via Twitter for Mac
RT @MathCancer: @CancerSysBio Great work on modeling extrinsic sources of heterogeneity. T
ME gradients magnify stochastic differences in ABMs #icbppsocmath
RT @CorbininChicago: Can model of cachexia could help explain what we are starting to understand about NSAIDs and cachexia? http://t.co/9puIy6Cjt0
#icbppsocmath
RT @CorbininChicago: Can model of cachexia could help explain what we are starting to understand about NSAIDs and cachexia? http://t.co/9puIy6Cjt0
#icbppsocmath
RT @ara_anderson: Rycroft: Collagen is a highly nonlinear material, so he suggests using finite strain elasticity theory #icbppsocmath http://t.co/6h9vmEuSyh
RT @ara_anderson: USC PSOC Parag Mallick: An experimentally calibrated model of signalling in B-cell receptor pathway #icbppsocmath http://t.co/4fSCWUK5g0
@CancerSysBio, Fri Feb 27 20:15:45 +0000 2015, via Twitter for Mac
Also, shameless plug here - @sargoshoe has been working on some software for more omics integration: http://t.co/em0ABVJ4oR #icbppsocmath
@CancerSysBio, Fri Feb 27 20:17:00 +0000 2015, via Twitter for Mac
PM: found resistance is brought about by histone modifications that then lead to DNA methylation changes. #icbppsocmath
RT @ara_anderson: USC PSOC Parag Mallick: An experimentally calibrated model of signalling in B-cell receptor pathway #icbppsocmath http://t.co/4fSCWUK5g0
RT @ara_anderson: Xavier: shows us a beautiful integration between in vitro, in silico & in vivo systems #icbppsocmath @mathonco http://t.co/ADDD3R7jGl
RT @ara_anderson: OHSU ICBP Roel Dobbe: leveraging novel methods for high dim data analysis & system ID in cancer biology #icbppsocmath http://t.co/1cGYiTQoaI
@CancerSysBio, Fri Feb 27 20:53:12 +0000 2015, via Twitter for Mac
Ji-Ping Wang from northwestern PSOC #icbppsocmath looking at @TCGAupdates data!
@CancerSysBio, Fri Feb 27 20:57:09 +0000 2015, via Twitter for Mac
J-PW models each type of data in TCGA as a bayesian network. Question: how to define network structure? #icbppsocmath
Northwestern PSOC Ji-Ping Wang: Modeling casualties of mixed features in TCGA data usin Bayesian netwrk #icbppsocmath http://t.co/Iok2iUMOKQ
@CancerSysBio, Fri Feb 27 21:00:39 +0000 2015, via Twitter for Mac
J-PW: common prob with bayesian network construction: how to handle both continuous and discrete variables in same structure? #icbppsocmath
@CancerSysBio, Fri Feb 27 21:01:08 +0000 2015, via Twitter for Mac
RT @ara_anderson: Northwestern PSOC Ji-Ping Wang: Modeling casualties of mixed features in TCGA data usin Bayesian netwrk #icbppsocmath http://t.co/Iok2iUMOKQ
@CancerSysBio, Fri Feb 27 21:02:37 +0000 2015, via Twitter for Mac
Next up, @sargoshoe from the MIT ICBP. She's on the job market, so check out her research here: http://t.co/EYD9Nioqlm #icbppsocmath
@CancerSysBio, Fri Feb 27 21:54:46 +0000 2015, via Twitter for Mac
RT @ara_anderson: MIT ICBP @sargoshoe Transcriptionam networks amplify microRNA effects: new expln for microRNA paradox m #icbppsocmath http://t.co/zQGR2BxAIJ
RT @ara_anderson: Sasha Popel: Computational modeling & experimental studies of breast cancer progression and metastasis #icbppsocmath http://t.co/HeG5KnO1T8
RT @ara_anderson: Sasha Popel: Computational modeling & experimental studies of breast cancer progression and metastasis #icbppsocmath http://t.co/HeG5KnO1T8
RT @ara_anderson: Popel discusses his work on complex tumour and organ microenvironments @MathCancer will be interested! #icbppsocmath http://t.co/XVdPIDmcQd
RT @ara_anderson: Popel discusses his work on complex tumour and organ microenvironments @MathCancer will be interested! #icbppsocmath http://t.co/XVdPIDmcQd
RT @ara_anderson: Popel: Organ residing lymphatic endothelial cells play a central role in metastatic axis IL6-CCL5-CCR5 #icbppsocmath http://t.co/HKvANUd75E
Popel shows some of his gorgeous reconstructed 3D vascular beds with realistic simulated flow #icbppsocmath http://t.co/ij1jMLIBnb
@CancerSysBio, Sat Feb 28 14:50:24 +0000 2015, via Twitter for Mac
RT @ara_anderson: Sasha Popel: Computational modeling & experimental studies of breast cancer progression and metastasis #icbppsocmath http://t.co/HeG5KnO1T8
RT @ara_anderson: Baumann it's easy to optimize therapy in a model but the hard part is to build a model worth optimizing #icbppsocmath
@CancerSysBio, Sat Feb 28 15:27:48 +0000 2015, via Twitter for Mac
Next up, @dbasanta from the @mathonco talking about new treatments in prostate cancer bone metastases. #icbppsocmath
@CorbininChicago, Sat Feb 28 15:28:36 +0000 2015, via Twitter Web Client
RT @CancerSysBio: Next up, @dbasanta from the @mathonco talking about new treatments in prostate cancer bone metastases. #icbppsocmath
@CancerSysBio, Sat Feb 28 15:28:47 +0000 2015, via Twitter for Mac
DB: Quotes einstein - "Everything should be made as simple as possible, but not simpler". Great mantra for modeling in cancer #icbppsocmath
@CorbininChicago, Sat Feb 28 15:29:06 +0000 2015, via Twitter Web Client
RT @CancerSysBio: DB: Quotes einstein - "Everything should be made as simple as possible, but not simpler". Great mantra for modeling in cancer #icbppsocmath
RT @ara_anderson: Baumann shows compact ode model with 4 steady states that correlate with distinct breast cancer states #icbppsocmath http://t.co/ItYoMbDMPf
RT @ara_anderson: Baumann shows the impact of drug holidays: resistant relaxation and return to sensitization #icbppsocmath Of course when & how long is key!
RT @CancerSysBio: DB: Quotes einstein - "Everything should be made as simple as possible, but not simpler". Great mantra for modeling in cancer #icbppsocmath
RT @ara_anderson: Moffitt ICBP @dbasanta An integrated framework to test treatments in bone metastatic prostate cancer #icbppsocmath http://t.co/CVTD8AjoX4
@CancerConnector, Sat Feb 28 15:38:00 +0000 2015, via Twitter for iPhone
RT @ara_anderson: Popel discusses his work on complex tumour and organ microenvironments @MathCancer will be interested! #icbppsocmath http://t.co/XVdPIDmcQd
.@dbasanta His model predicts that TGF-Beta inhibitor pre-treatment is critical for therapeutic success #icbppsocmath http://t.co/5ziWGF025X
@CancerConnector, Sat Feb 28 15:43:17 +0000 2015, via Twitter for iPhone
RT @ara_anderson: Baumann shows compact ode model with 4 steady states that correlate with distinct breast cancer states #icbppsocmath http://t.co/ItYoMbDMPf
@CancerConnector, Sat Feb 28 15:43:20 +0000 2015, via Twitter for iPhone
RT @MathCancer: Haven't seen this in awhile! Baumann does phase plane analysis on 2-ODE signaling system at #icbppsocmath
@cancerassassin1, Sat Feb 28 15:43:23 +0000 2015, via Twitter for iPhone
RT @MathCancer: Baumann's model says "drug holiday" can reset system, open new window of drug effectiveness. Interesting idea! #icbppsocmath
RT @ara_anderson: .@dbasanta His model predicts that TGF-Beta inhibitor pre-treatment is critical for therapeutic success #icbppsocmath http://t.co/5ziWGF025X
@CancerConnector, Sat Feb 28 15:43:50 +0000 2015, via Twitter for iPhone
RT @MathCancer: Next speaker at #icbpsocmath is @dbasanta. An integrated framework to test treatments of PCa bone metastases. Work with @AutumnDude
@CancerConnector, Sat Feb 28 15:44:08 +0000 2015, via Twitter for iPhone
RT @ara_anderson: Baumann it's easy to optimize therapy in a model but the hard part is to build a model worth optimizing #icbppsocmath
RT @ara_anderson: .@dbasanta His model predicts that TGF-Beta inhibitor pre-treatment is critical for therapeutic success #icbppsocmath http://t.co/5ziWGF025X
@CancerConnector, Sat Feb 28 15:44:54 +0000 2015, via Twitter for iPhone
RT @MathCancer: A great use for fast and simple CA models: rapid testing of hypotheses. Is a treatment idea worthwhile? @dbasanta at #icbppsocmath
@CancerSysBio, Sat Feb 28 15:46:45 +0000 2015, via Twitter for Mac
DB: Great way of building models based on patient data, then use math models to improve outcome. #icbppsocmath #translationalresearch
RT @CancerSysBio: DB: Great way of building models based on patient data, then use math models to improve outcome. #icbppsocmath #translationalresearch
Princeton PSOC David Liao: Using criticality landscape to develop strategies to control heterogeneity #icbppsocmath http://t.co/Y3RZSdPjnm
@sargoshoe, Sat Feb 28 16:14:29 +0000 2015, via Twitter for Mac
RT @ara_anderson: MIT ICBP @sargoshoe Transcriptionam networks amplify microRNA effects: new expln for microRNA paradox m #icbppsocmath http://t.co/zQGR2BxAIJ
RT @CancerSysBio: Here Bansal uses Kullback Leibler divergence to measure dysregulation of genes upon drug treatment: http://t.co/nrRkuEBiDV #icbppsocmath
@CancerSysBio, Sat Feb 28 16:32:15 +0000 2015, via Twitter for Mac
MB claims that "if a gene is a direct target of a drug it will be differentially expressed". How exactly? #icbppsocmath
RT @MathCancer: Popel showing fantastic VEGFR network & treatment modeling by @USCSysBio_Lab at #icbppsocmath meeting. That work continues at @USCViterbi!
@CancerConnector, Sat Feb 28 17:16:25 +0000 2015, via Twitter for iPhone
RT @MathCancer: next up at #icbppsocmath is @lookatphysics. Speaking on criticality landscapes with Bob Austin and friends
@CancerConnector, Sat Feb 28 17:18:00 +0000 2015, via Twitter for iPhone
RT @CancerSysBio: Here Bansal uses Kullback Leibler divergence to measure dysregulation of genes upon drug treatment: http://t.co/nrRkuEBiDV #icbppsocmath
RT @ara_anderson: Thanks to all #icbppsocmath attendees for making that a great meeting! It been a packed 2 days but lots of fun! http://t.co/km0h3s23e4
RT @ara_anderson: Thanks to all #icbppsocmath attendees for making that a great meeting! It been a packed 2 days but lots of fun! http://t.co/km0h3s23e4
RT @ara_anderson: Thanks to all #icbppsocmath attendees for making that a great meeting! It been a packed 2 days but lots of fun! http://t.co/km0h3s23e4
RT @ara_anderson: Thanks to all #icbppsocmath attendees for making that a great meeting! It been a packed 2 days but lots of fun! http://t.co/km0h3s23e4